NBTX · NASDAQ
Nanobiotix (NBTX) Stock Price & Fundamentals
Nanobiotix (NBTX) closed at $524.21 on Oct 9, 2026, down 0.43% from the previous close of $526.46.
Share price, past year
1Y +7.80%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $524.21 |
| Sep 30, 2026 | $539.72 |
| Aug 31, 2026 | $515.21 |
| Jul 31, 2026 | $542.07 |
| Jun 30, 2026 | $520.32 |
| May 29, 2026 | $503.27 |
| Apr 30, 2026 | $501.78 |
| Mar 31, 2026 | $513.86 |
| Feb 27, 2026 | $499.44 |
| Jan 30, 2026 | $481.60 |
| Dec 31, 2025 | $481.13 |
| Nov 28, 2025 | $490.23 |
| Oct 31, 2025 | $503.91 |
Key statistics
- Market cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 48.4M
- Dividend yield
- —
- 52-week range
- $462.69 – $551.68
Market cap, P/E and dividend yield aren't shown for Nanobiotix yet: its SEC filings count its ordinary shares, which can differ from the shares traded in the US, and report in euros.
Financials
Nanobiotix reported revenue of €32.59M for fiscal 2025, up 553.25% from fiscal 2024.
Figures are in euros (EUR), as Nanobiotix reports them to the SEC.
Nanobiotix reported a net loss of €23.96M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | €32.59M | +553.3% | −€23.96M | −73.5% | −€0.50 | −€33.96M |
| FY2024ended Dec 31, 2024 | −€7.19M | −119.9% | −€68.13M | 947.5% | −€1.44 | −€20.40M |
| FY2023ended Dec 31, 2023 | €36.21M | +658.1% | −€39.70M | −109.7% | −€1.08 | −€12.80M |
| FY2022ended Dec 31, 2022 | €4.78M | +80.4% | −€57.04M | −1,194.3% | −€1.64 | −€37.20M |
| FY2021ended Dec 31, 2021 | €2.65M | +5.4% | −€47.06M | −1,778.0% | −€1.35 | −€30.10M |
| FY2020ended Dec 31, 2020 | €2.51M | −1.1% | −€33.59M | −1,337.2% | −€1.38 | −€27.63M |
| FY2019ended Dec 31, 2019 | €2.54M | −27.0% | −€50.92M | −2,003.7% | −€2.35 | −€42.26M |
| FY2018ended Dec 31, 2018 | €3.48M | — | −€30.35M | −872.2% | −€1.55 | −€26.40M |
Company profile
- Name
- Nanobiotix S.A.
- Ticker
- NBTX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 60 Rue De Wattignies, Paris, I0 75012
- Incorporated in
- I0
- Fiscal year ends
- December
- SEC CIK
- 0001760854
Recent SEC filings
- Mar 31, 2026
- Apr 2, 2025
- Apr 24, 2024
- Apr 24, 2023
- Apr 8, 2022
- Apr 8, 2021
- Apr 7, 2021
Frequently asked questions
What is Nanobiotix's stock price?
Nanobiotix (NBTX) closed at $524.21 on Oct 9, 2026, down 0.43% from the previous close of $526.46.
How much revenue does Nanobiotix make?
Nanobiotix reported revenue of €32.59M for fiscal 2025, up 553.25% from fiscal 2024.
Sources and methodology
Fundamentals come from Nanobiotix S.A.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures